Literature DB >> 25152348

Endoscopic thoracic sympathectomy.

Eleni Moraites1, Olushola Akinshemoyin Vaughn2, Samantha Hill3.   

Abstract

Endoscopic thoracic sympathectomy is a surgical technique most commonly used in the treatment of severe palmar hyperhidrosis in selected patients. The procedure also has limited use in the treatment axillary and craniofacial hyperhidrosis. Endoscopic thoracic sympathectomy is associated with a high rate of the development of compensatory hyperhidrosis, which may affect patient satisfaction with the procedure and quality of life.
Copyright © 2014 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Axillary hyperhidrosis; Endoscopic thoracic sympathectomy; Hyperhidrosis; Palmar hyperhidrosis; Quality of life

Mesh：

Year:  2014        PMID： 25152348     DOI： 10.1016/j.det.2014.06.007

Source DB:  PubMed          Journal:  Dermatol Clin        ISSN： 0733-8635            Impact factor:   3.478


  4 in total

1.  Early results of new endoscopic thoracic sympathectomy for craniofacial hyperhidrosis.

Authors:  Duk Hwan Moon; Du-Young Kang; Dong Won Kim; Min Kyun Kang; Sungsoo Lee
Journal:  J Thorac Dis       Date:  2018-06       Impact factor: 2.895

2.  Management Strategies Of Palmar Hyperhidrosis: Challenges And Solutions.

Authors:  Stamatios Gregoriou; Polytimi Sidiropoulou; Georgios Kontochristopoulos; Dimitrios Rigopoulos
Journal:  Clin Cosmet Investig Dermatol       Date:  2019-10-04

3.  Hyperhidrosis, Endoscopic Thoracic Sympathectomy, and Cardiovascular Outcomes: A Cohort Study Based on the Korean Health Insurance Review and Assessment Service Database.

Authors:  Jae-Min Park; Duk Hwan Moon; Hye Sun Lee; Ju-Young Park; Ji-Won Lee; Sungsoo Lee
Journal:  Int J Environ Res Public Health       Date:  2019-10-15       Impact factor: 3.390

4.  Electrophysiological evaluation of efficacy of clipping in thoracic sympathectomy: An experimental cadaveric study.

Authors:  Hakan Salcı; Hilal Acar; Mevlüt Özgür Taşkapılıoğlu; Hüseyin Melek; Ahmet Sami Bayram
Journal:  Turk Gogus Kalp Damar Cerrahisi Derg       Date:  2020-10-21       Impact factor: 0.332
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.